Serum a proliferation-inducing ligand and MicroRNA-223 are associated with rheumatoid arthritis: diagnostic and prognostic implications
Open Access
- 1 October 2020
- journal article
- research article
- Published by Springer Nature in Molecular Medicine
- Vol. 26 (1) , 1-9
Abstract
Background: Current blood-based tests for rheumatoid arthritis (RA) have inherent limitations, necessitating the need for additional new biomarkers for its diagnosis and monitoring disease activity and responsiveness to therapy. MicroRNAs (miRNAs) and a proliferation-inducing ligand (APRIL) are deregulated in RA and were linked to its pathogenesis. This study investigated serum levels of APRIL, miR-223 and miR-155 in RA patients, their potential as diagnostic and prognostic biomarkers, and their correlation with disease activity and clinicopathological data. Methods: One hundred and twenty Egyptian patients with RA and 130 healthy controls were included. Serum miRNAs and APRIL were assayed by RT-qPCR and ELISA, respectively. Results: Serum APRIL and miR-223 were significantly upregulated, while miR-155 was unchanged in RA patients compared to controls. Serum miR-223 discriminated RA patients from controls with AUC = 0.85, whereas serum APRIL superiorly distinguished the two groups with AUC = 1 (sensitivity and specificity = 100% at cutoff> 4.19 ng/ml) by receiver-operating-characteristic analysis. Serum miR-223 was a significant predictor for RA diagnosis in multivariate logistic regression analysis. In RA group, serum APRIL was positively correlated with disease activity score (DAS28-CRP). Serum miR-223 expression was positively correlated with serum miR-155, APRIL levels and with the presence of subcutaneous nodules. Serum miR-155 levels were correlated with antinuclear antibody titer in reverse direction. Conclusion: Our results suggest serum APRIL and miR-223 could serve as potential biomarkers of RA, with miR-223 as a predictor of RA risk and APRIL as an excellent biomarker of disease activity. Our data could be implicated for accurate and blood-based non-invasive diagnosis and prognosis of RA.Keywords
All Related Versions
This publication has 42 references indexed in Scilit:
- Rheumatoid arthritis is an autoimmune disease caused by periodontal pathogensInternational Journal of General Medicine, 2013
- Macrophage microvesicles induce macrophage differentiation and miR-223 transferBlood, 2013
- APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritisArthritis Research & Therapy, 2012
- Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiationModern Rheumatology, 2012
- MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritisProceedings of the National Academy of Sciences, 2011
- miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-βCell Research, 2010
- Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritisArthritis Research & Therapy, 2010
- Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patientsArthritis Research & Therapy, 2008
- Requirement of bic/microRNA-155 for Normal Immune FunctionScience, 2007
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995